AAML1831: A Phase III Trial Comparing Standard Induction Therapy With CPX-351 in De Novo Pediatric AML: A Report From the Children's Oncology Group

Jessica A. Pollard, Todd A. Alonzo, Robert B. Gerbing, Matthew Kutny, Betsy Hirsch, Gordana Raca, Kasey Leger, Jennifer Wilkes, Reena Pabari, Aman Wadhwa, Zachary Graff, Samir Kahwash, Karen Chisholm, Joseph Chewning, John Horan, Richard Aplenc, Andrew Place, Sarah K. Tasian, Katherine Tarlock, Sarah Menig, Olga Militano, Bonnie Ky, Chad Hudson, Michael R. Loken, Andrew Menssen, Lisa Eidenschink Brodersen, Soheil Meshinchi, Edward Anders Kolb, Todd M. Cooper

Open source

DOI: 10.1200/jco-25-02979
Published: 2026-09-20
Container: Journal of Clinical Oncology
Publisher: American Society of Clinical Oncology (ASCO)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/jco-25-02979,
  title = {AAML1831: A Phase III Trial Comparing Standard Induction Therapy With CPX-351 in De Novo Pediatric AML: A Report From the Children's Oncology Group},
  author = {Jessica A. Pollard and Todd A. Alonzo and Robert B. Gerbing and Matthew Kutny and Betsy Hirsch and Gordana Raca and Kasey Leger and Jennifer Wilkes and Reena Pabari and Aman Wadhwa and Zachary Graff and Samir Kahwash and Karen Chisholm and Joseph Chewning and John Horan and Richard Aplenc and Andrew Place and Sarah K. Tasian and Katherine Tarlock and Sarah Menig and Olga Militano and Bonnie Ky and Chad Hudson and Michael R. Loken and Andrew Menssen and Lisa Eidenschink Brodersen and Soheil Meshinchi and Edward Anders Kolb and Todd M. Cooper},
  year = {2026},
  journal = {Journal of Clinical Oncology},
  doi = {10.1200/jco-25-02979},
  url = {https://doi.org/10.1200/jco-25-02979}
}

RIS

TY  - JOUR
TI  - AAML1831: A Phase III Trial Comparing Standard Induction Therapy With CPX-351 in De Novo Pediatric AML: A Report From the Children's Oncology Group
AU  - Jessica A. Pollard
AU  - Todd A. Alonzo
AU  - Robert B. Gerbing
AU  - Matthew Kutny
AU  - Betsy Hirsch
AU  - Gordana Raca
AU  - Kasey Leger
AU  - Jennifer Wilkes
AU  - Reena Pabari
AU  - Aman Wadhwa
AU  - Zachary Graff
AU  - Samir Kahwash
AU  - Karen Chisholm
AU  - Joseph Chewning
AU  - John Horan
AU  - Richard Aplenc
AU  - Andrew Place
AU  - Sarah K. Tasian
AU  - Katherine Tarlock
AU  - Sarah Menig
AU  - Olga Militano
AU  - Bonnie Ky
AU  - Chad Hudson
AU  - Michael R. Loken
AU  - Andrew Menssen
AU  - Lisa Eidenschink Brodersen
AU  - Soheil Meshinchi
AU  - Edward Anders Kolb
AU  - Todd M. Cooper
PY  - 2026
JO  - Journal of Clinical Oncology
DO  - 10.1200/jco-25-02979
UR  - https://doi.org/10.1200/jco-25-02979
ER  -

APA

Pollard, J. A., Alonzo, T. A., Gerbing, R. B., Kutny, M., Hirsch, B., Raca, G., Leger, K., Wilkes, J., Pabari, R., Wadhwa, A., Graff, Z., Kahwash, S., Chisholm, K., Chewning, J., Horan, J., Aplenc, R., Place, A., Tasian, S. K., Tarlock, K., Menig, S., Militano, O., Ky, B., Hudson, C., Loken, M. R., Menssen, A., Brodersen, L. E., Meshinchi, S., Kolb, E. A., & Cooper, T. M. (2026). AAML1831: A Phase III Trial Comparing Standard Induction Therapy With CPX-351 in De Novo Pediatric AML: A Report From the Children's Oncology Group. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-02979

Source records

crossref · retrieved 2026-09-25T19:11:37.163Z